Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

VA Contract Update

10 May 2013 07:00

RNS Number : 3944E
Ideagen PLC
10 May 2013
 



 

Ideagen PLC

("Ideagen" or the "Company")

 

VA Contract Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions, announces that the Company has received notification from the US Department of Veterans Affairs (VA) to 'terminate for convenience' year two of the Prism contract expected to complete during November 2013. The cancellation of this contract has no effect on market expectations for the current financial year.

 

As notified in the announcement of 29 November 2012, approximately 70% of the anticipated revenue from year two of the contract of approximately £1.05 million was recognised in the financial period ending 30 April 2013. Given the current nature of the US Federal budgets the Company had made ample contingency within its business plan to ensure that in the event of this programme discontinuing following the second year of the contract there would be no impact on the current market expectations for the financial period ending 30 April 2014. The Company therefore remains confident in meeting market expectations for the financial period ending 30 April 2014.

 

The decision to terminate year two of the Prism contract was made for budgetary reasons and the Company remains a trusted and important supplier to the VA and will continue to support the existing deployment of Proquis Enterprise™ at 40 VA hospitals across the USA and to market its products to VA hospitals at a local and regional level.

 

The notice to 'terminate for convenience' the Company's Prism contract is a no fault termination right held by the US Government over all Federal Contracts and, as the Company has complied fully with all commercial and technical contractual obligations, it is entitled to a settlement under Federal Acquisition Regulation (FAR) 52.2124 (i) in respect of the second year of the contract to November 2013. The VA has requested a proposal for settlement from the Company which will be submitted as soon as possible.

 

David Hornsby, Chief Executive of Ideagen, commented, "Whilst we are disappointed that year two of the Prism contract has been terminated, I am pleased to report our budgetary processes were robust. The business continues to trade strongly and the Company remains confident of delivering further revenue and profit growth in the current financial period."

 

Enquiries:

 

 

Ideagen Plc

 

Tel: 01629 761590

David Hornsby, Chief Executive

 

 

Graeme Spenceley, Finance Director

 

 

 

 

 

finnCap (Nominated Adviser and Broker)

 

Tel: 020 7220 0500

Matt Goode/Charlotte Stranner (Corporate Finance)

 

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Westaway

 

Helen.westaway@walbrookpr.com

Paul Cornelius

 

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPSNEFKDEFF
Date   Source Headline
1st Jun 202211:45 amRNSForm 8.5 (EPT/RI)
1st Jun 202211:04 amRNSForm 8.3 - Ideagen plc
1st Jun 202211:00 amRNSForm 8.3 - Ideagen Plc
1st Jun 202210:20 amRNSForm 8.3 - IDEAGEN PLC
1st Jun 202210:17 amGNWForm 8.3 - Ideagen PLC
31st May 20223:29 pmRNSForm 8.5 (EPT/RI)- Amendment
31st May 20223:15 pmBUSForm 8.3 - Ideagen plc
31st May 20223:03 pmRNSForm 8.3 - Ideagen plc
31st May 202212:12 pmRNSForm 8.3 - Ideagen plc
31st May 202211:10 amRNSForm 8.5 (EPT/RI)
31st May 202211:04 amBUSForm 8.3 - IDEAGEN PLC
31st May 20229:59 amRNSForm 8.3 - Ideagen plc
31st May 20229:55 amGNWForm 8.3 - Ideagen PLC
30th May 20224:45 pmRNSDirector/PDMR Shareholding
30th May 20224:01 pmBUSForm 8.3 - Ideagen plc
30th May 20223:30 pmRNSHolding(s) in Company
30th May 20223:00 pmBUSForm 8.3 - IDEA LN
30th May 20222:47 pmRNSForm 8.3 - Ideagen Plc
30th May 20221:01 pmGNWForm 8.3 - [Ideagen plc - 27 05 2022] - (CGWL)
30th May 202212:29 pmRNSForm 8.3 - Ideagen plc
30th May 202212:16 pmGNWForm 8.3 - Ideagen PLC
30th May 202212:09 pmRNSForm 8.3 - Ideagen plc
30th May 202211:15 amRNSPublication of Scheme Document
30th May 202211:09 amRNSForm 8.5 (EPT/RI)
30th May 202211:02 amRNSForm 8.5 (EPT/RI)
30th May 202210:29 amGNWForm 8.3 - Ideagen Plc
30th May 202210:04 amRNSForm 8.3 - Ideagen PLC
30th May 20227:07 amRNSForm 8.5 (EPT/RI) - Amendment
27th May 20223:20 pmRNSForm 8.3 - Ideagen plc
27th May 20223:15 pmBUSForm 8.3 - Ideagen plc
27th May 20222:35 pmRNSForm 8.3 - Ideagen PLC
27th May 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
27th May 202212:15 pmRNSForm 8.3 - Ideagen plc
27th May 202211:59 amGNWForm 8.3 - [IDEAGEN PLC - 26 05 2022] - CGWL
27th May 202211:43 amRNSForm 8.3 - Ideagen plc
27th May 202211:34 amRNSForm 8.5 (EPT/RI)
27th May 202210:43 amRNSForm 8.3 - Ideagen plc
27th May 202210:42 amGNWForm 8.3 - Ideagen PLC
27th May 202210:00 amGNWForm 8.3 - Ideagen PLC
26th May 20223:20 pmRNSForm 8.3 - Ideagen plc
26th May 20223:15 pmBUSForm 8.3 - Ideagen plc
26th May 20221:15 pmRNSForm 8.3 - Ideagen plc
26th May 202212:29 pmRNSForm 8.3 - Ideagen plc
26th May 202212:10 pmGNWForm 8.3 - [IDEAGEN PLC - 25 05 2022] - CGWL
26th May 202211:38 amRNSForm 8.3 - Ideagen Plc
26th May 202211:06 amRNSForm 8.5 (EPT/RI)
26th May 202210:49 amGNWForm 8.3 - Ideagen PLC
26th May 202210:31 amRNSRule 2.9 Announcement
26th May 202210:30 amRNSIssue of Equity and TVR
26th May 20229:57 amRNSForm 8.3 - Ideagen Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.